Cardiac resynchronization therapy reduces the risk of cardiac events in patients with diabetes enrolled in the multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy (MADIT-CRT).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples